10 Mar 2022
Monoclonal antibodies – the new kid on the block for managing OA
Ahead of his lecture on this topic at BSAVA Congress, Matt Gurney discusses his early experiences of using this treatment approach and explains how the role of nerve growth factor is an untapped pathway in the management of this disease…
Matt Gurney
Job Title
- An article version can be found in the 2022 issue of BSAVA Congress Times – look out for your print copy, delivered with Vet Times 52.10 (8 March issue).